As^ptJe°mbenhia89^'}    American  Pharmaceutical  Association.  509 
ship.  He  was  of  the  opinion  that  the  Association  had  followed  the  "  drag-net  " 
policy  long  enough.  Chairman  C.  E.  Dohme,  of  the  Finance  Committee,  re- 
ported for  that  body  that  expenses  had  increased  during  the  past  year,  and  that 
the  income  had  not  come  up  to  expectations.  Prof.  Hallberg  moved  to  receive 
and  publish  the  report  ;  also,  in  a  second  motion,  to  cheapen  the  Proceedings. 
These  matters  were  referred  to  the  Publication  Committee. 
The  reports  of  the  Committees  on  Publication  and  Investments  were  received, 
adopted  and  ordered  to  be  published.  The  report  of  the  Committee  on  the 
Revision  of  the  Pharmacopoeia  was  read  by  title  and  referred  to  the  Scientific 
Section  for  consideration  and  discussion.  Secretary  Caspari  then  read  the  report 
of  the  Committee  on  General  Prizes  for  papers  presented  at  the  last  meeting  in 
Denver.  The  first  prize  was  awarded  to  Edward  Kremers  for  his  paper  "  On  the 
Chemical  Composition  of  the  Volatile  Oil  from  Monarda  fistulosa  ;  the  second 
to  Edson  S.  Bastin,  for  his  contribution  on  "The  Structure  of  Our  Cherry 
Barks;"  and  the  third  to  Mr.  A.  R.  L.  Dohme  for  his  several  papers  on 
"Aconitine  and  Assays  of  Ergot,  Pilocarpus,  Coca  Leaves  and  Ipecac  Stems." 
The  report  was  adopted.  The  Committee  on  Ebert  Prize  did  not  find  any  of 
the  papers  presented  at  the  last  meeting  to  meet  the  requirements,  although 
they  recognized  the  good  quality  of  many  of  those  submitted.  Prof.  Hallberg 
suggested  the  establishment  of  a  beneficiary  fund,  and  moved  that  a  committee 
of  three  be  appointed  to  consider  the  feasibility  of  adopting  such  measures. 
The  motion  was  carried.  The  session  then  took  a  recess  until  3  p.m.,  when 
President  Good  called  it  to  order  again.  Secretary  Caspari  read  the  report  of 
the  delegates  to  the  American  Medical  Association.  The  report  was  accepted, 
and  as  that  body  desired  the  American  Pharmaceutical  Association  to  continue 
to  send  delegates  it  was  so  ordered  by  the  latter.  It  was  moved  that  a  commit- 
tee be  appointed  to  take  up  the  suggestion  of  Prof.  Rusby,  for  the  consideration 
of  joint  investigation  by  the  sections  of  materia  medica,  therapy  and  phar- 
macy of  the  two  associations  referred  to  above.  It  was  amended  to  refer  this 
suggestion  to  the  Scientific  Section  for  action.  The  amended  motion  was 
carried. 
Chairman  Whelpley  read  the  report  of  the  Special  Auxiliary  Committee  on 
Membership.  Mr.  Ebert  moved  to  receive  it  and  thank  the  committee  for 
their  work,  also  to  continue  the  committee  and  to  thank  the  pharmaceutical 
press  for  their  aid  to  the  committee.  The  Committee  on  National  Legislation, 
created  in  Denver  at  the  last  meeting,  submitted  a  report  through  its  chairman, 
F.  E.  Stewart,  which  document  contained  an  exhaustive  dissertation  on  the 
present  patent  and  trade-mark  laws  of  the  United  States,  and  concluded  with 
the  following  recommendation  : 
"  Your  Committee  would,  therefore,  suggest  that  a  memorial  be  drawn  up, 
stating  the  reasons  why  pharmacy  should  be  afforded  relief  from  the  trade 
competition  which  threatens  its  very  existence  as  a  profession,  and  embodying 
our  complaint  in  relation  to  the  misconstruction  of  copyright  and  trade-mark 
laws,  which  are  seriously  injuring  the  science  and  practice  of  pharmacy,  and 
sending  the  same  to  the  United  States  Congress,  to  every  pharmacal  and  medi- 
cal society,  to  the  American  Public  Health  Association,  and  the  National  Bar 
Association.  Then  let  us  keep  close  watch  of  the  courts,  and  throw  our  aid 
and  influence  on  the  side  of  the  right  in  every  case  where  the  pharmacist  is  in 
the  toils  of  the  law — not  to  support  infringements  of  patents,  copyrights  or 
